Liver Diseases  >>  mericitabine (RG7128)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mericitabine (RG7128) / Gilead, Roche
NCT00801255: A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients

Checkmark INFORM-1
Jun 2011 - Jun 2011: INFORM-1
Completed
1
88
RoW
RO5024048, danoprevir
Hoffmann-La Roche
Hepatitis C, Chronic
03/10
03/10

Download Options